Skip to main content
. Author manuscript; available in PMC: 2015 Jan 15.
Published in final edited form as: Clin Cancer Res. 2013 Nov 11;20(2):331–343. doi: 10.1158/1078-0432.CCR-13-1736

Table 2.

Reactivity of bulk CD8+ tumor infiltrating lymphocytes to autologous cancer cell lines

Pt. 3 Gastric Ca. CD8+ TIL Pt. 5 Biliary tract Ca. CD8+ TIL Pt. 9 Colon Ca. CD8+ TIL
pg/ml IFN-γ (% 4-1BB+) pg/ml IFN-γ (% 4-1BB+) pg/ml IFN-γ (% 4-1BB+)




pOKT3 2302 (92.3) 1650 (38.3) 607 -
Medium 80 (0.2) 71 (0.3) 75 (0.2)




Autologous cancer cell GALMa 1236 (66.2) BAOMa 76 (0.7) CALM 200 (15.7)
GALMb 50 (1.7) BAAM 68 (1.0)
GALMc 55 (1.0)
GALMd 2046 (83.5)




Allogeneic cancer cell Mel.624 37 (0.3) GALMa 79 (0.1) GALMd 62 -
BAOMa 66 -

NOTE: Mean IFN-γ secretion (pg/ml) in 24 h co-culture supernatants of CD8+ TIL with autologous and allogeneic cancer cell lines in representative independant experiments. After sampling each well for IFN-γ, TIL duplicates were pooled and harvested for 4-1BB staining for flow cytometry analysis (in parenthesis, percent of CD8+ cells, gated on CD3+ cells). Bolded values for IFN-γ reflect secretion of at least 200 pg/ml, whereas bolded 4-1BB+ reflects specific upregulation at least twice as high as the unstimulated condition (media).

Abbreviations: Pt., patient; pOKT3, plate bound anti-CD3.